Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2008

View Archived Issues

Abbott identifies novel Tie-2 inhibitors active against cancer in preclinical studies

Trial demonstrates immunomodulating effects of COLD-fX

Medtronic commences U.S. and international Endeavor Resolute stent trials

Invitrogen and Biocare to market FDA approved SPOT-Light HER2 CISH Kit

Odanacatib suppresses bone resorption in breast cancer with established bone metastases

Threshold begins phase I/II study for TH-302 in patients with soft tissue sarcoma

Temoporfin improves tumoricidal depth in photodynamic therapy for bile duct cancer

Long-term safety for Diamyd vaccination in phase II autoimmune diabetes study

GSK and XenoPort submit NDA to FDA for Solzira in restless legs syndrome

Novavax tests seasonal influenza VLP vaccine candidate in phase II trial

Neuropharma changes name to Noscira, announces completion of phase I trials of NP-12

Priority review for Coartem

Compugen discovers peptide drug candidate for treatment of solid tumors

New therapeutic agents for HCV infection disclosed in recent patents

Recent patents report novel analgesic agents

New anti-HIV agents described in recent Myriad and Novartis patents

Mymetics achieves successful results in mucosal HIV/AIDS vaccine viral challenge

Myriad presents top-line results from phase I Vivecon trial

Clinical results of PANVAC-VF in metastatic breast cancer reported

China Biologic receives SFDA approval for human coagulation factor VIII trial

Depomed initiates phase III program for Gabapentin GR in menopausal hot flashes

DXL-625 shows superiority to Rituxan in animal studies

FDA approves expanded uses for Gardasil

Oramed initiates GLP1 analogue program with ORMD-0901

Davanat data filed for registration in late-stage colorectal cancer

Merck Serono commences ORACLE MS trial to evaluate Cladribine in MS

S*BIO initiates U.S. phase I trials of oral JAK2 inhibitor SB-1518

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...